FDA Approves Botox Challenger Daxxify for Frown Lines

Österreich Nachrichten Nachrichten

FDA Approves Botox Challenger Daxxify for Frown Lines
Österreich Neuesten Nachrichten,Österreich Schlagzeilen
  • 📰 Medscape
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 55%

FDA has approved daxibotulinumtoxinA-lanm injection for the temporary improvement in the appearance of moderate to severe glabellar lines in adults.

release inhibitor and neuromuscular blocking agent, is the first peptide-formulated, long-acting neuromodulator approved for this indication.

About three quarters of participants achieved at least a two-grade improvement in glabellar lines at week 4 as judged by both investigator and patient and 98% achieved"none or mild wrinkle severity" at week 4 per investigator assessment, the company said. "Compelling data from the largest phase 3 clinical program ever conducted for glabellar lines demonstrated that Daxxify was well tolerated and achieved clinically significant improvement with long-lasting results and high patient satisfaction," SAKURA investigator Jeffrey Dover, MD, co-director of SkinCare Physicians, Chestnut Hill, Massachusetts, said in the news release.

Wir haben diese Nachrichten zusammengefasst, damit Sie sie schnell lesen können. Wenn Sie sich für die Nachrichten interessieren, können Sie den vollständigen Text hier lesen. Weiterlesen:

Medscape /  🏆 386. in US

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Revance Shares Jump 18% After FDA Approves Botox Rival DaxxifyRevance Shares Jump 18% After FDA Approves Botox Rival DaxxifyShares of Revance Therapeutics surged 18% Thursday after the company announced the Food and Drug Administration had approved Daxxify.
Weiterlesen »

FDA Approves New Botox RivalFDA Approves New Botox RivalThe U.S. Food and Drug Administration approved a new antiwrinkle treatment that could be the most formidable challenger to date to market leader Botox
Weiterlesen »

'A Disgrace': Ron Johnson Says He Opposes Same-Sex Marriage Bill'A Disgrace': Ron Johnson Says He Opposes Same-Sex Marriage Bill'He's unfit for public office,' responded progressive challenger TheOtherMandela.
Weiterlesen »

PolitiFact - What Herschel Walker gets wrong, and right, about federal funding for more treesPolitiFact - What Herschel Walker gets wrong, and right, about federal funding for more treesU.S. Senate candidate Herschel Walker is right about 1.5 billion being spent on efforts to bolster urban tree cover. He exaggerated when he said the bill will 'raise taxes' on middle- and lower-income Americans.
Weiterlesen »

Arlington Heights trustees hire consultants for financial, traffic studies of Chicago Bears’ stadium plansArlington Heights trustees hire consultants for financial, traffic studies of Chicago Bears’ stadium plansArlington Heights trustees approved hiring traffic and finance consultants for studies related redeveloping Arlington International Racecourse.
Weiterlesen »

Friendswood budget based on flat tax rate would still result in higher tax bills for manyFriendswood budget based on flat tax rate would still result in higher tax bills for manyFriendswood City Council has unanimously approved a $114.2 million 2023 fiscal year...
Weiterlesen »



Render Time: 2025-04-04 23:02:49